Kimberley Stannard

2.7k citations

17 papers · 1.6k indexed · h-index 16

Co-authors: Mark J. Smyth Michele W.L. Teng Deepak Mittal Arabella Young John Stagg Michelle C.R. Yong Deborah S. Barkauskas Kazuyoshi Takeda
Topics: Immune Cell Function and Interaction (10 papers)Cancer Immunotherapy and Biomarkers (8 papers)Adenosine and Purinergic Signaling (5 papers)
Cited by: Physiology Immunology Oncology
Journals: Blood Cancer Research Cancer Letters
Partner nations: Australia Japan France

In The Last Decade

Kimberley Stannard

17 papers receiving 1.6k citations

Peers

Countries citing papers authored by Kimberley Stannard

Since Specialization

Citations

This map shows the geographic impact of Kimberley Stannard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberley Stannard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberley Stannard more than expected).

Fields of papers citing papers by Kimberley Stannard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberley Stannard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberley Stannard. The network helps show where Kimberley Stannard may publish in the future.

Co-authorship network of co-authors of Kimberley Stannard

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberley Stannard. A scholar is included among the top collaborators of Kimberley Stannard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberley Stannard. Kimberley Stannard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Systemic administration of IL‐33 induces a population of circulating KLRG1^hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma 2020 ·Immunology and Cell Biology ·Camille Guillerey,Kimberley Stannard,Jason Chen,Sophie Krumeich,Kim Miles,Kyohei Nakamura,Jessica L. Smith,Yuan Yu,Susanna S. Ng,Heidi Harjunpää,Michele W.L. Teng,Christian Engwerda,Gabrielle T. Belz,Mark J. Smyth	8
2	CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function 2019 ·Cancer Immunology Research ·Deepak Mittal,Ailin Lepletier,Jason Madore,Amelia Roman Aguilera,Kimberley Stannard,Stephen J. Blake,Vicki Whitehall,Cheng Liu,Mark Bettington,Kazuyoshi Takeda,Georgina V. Long,Richard A. Scolyer,Ruth Y. Lan,Nathan O. Siemers,Alan J. Korman,Michele W.L. Teng,Robert J. Johnston,William C. Dougall,Mark J. Smyth	90
3	Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions 2019 ·Blood Advances ·Kimberley Stannard,Sébastien Lemoine,Nigel J. Waterhouse,Frank Vari,Lucienne Chatenoud,Maher K. Gandhi,Ludovic Martinet,Mark J. Smyth,Camille Guillerey	22
4	CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity 2018 ·OncoImmunology ·Amelia Roman Aguilera,Viviana P. Lutzky,Deepak Mittal,Xian-Yang Li,Kimberley Stannard,Kazuyoshi Takeda,Günter Bernhardt,Michele W.L. Teng,William C. Dougall,Mark J. Smyth	42
5	TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma 2018 ·Blood ·Camille Guillerey,Heidi Harjunpää,Nadège Carrié,Sahar Kassem,(unknown),Kim Miles,Sophie Krumeich,(unknown),Marine Cuisinier,Kimberley Stannard,Yu Yuan,Simone A. Minnie,Geoffrey R. Hill,William C. Dougall,Hervé Avet‐Loiseau,Michele W.L. Teng,Kyohei Nakamura,Ludovic Martinet,Mark J. Smyth	222
6	The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor‐infiltrating T cells 2018 ·Immunology and Cell Biology ·Ailin Lepletier,Viviana P. Lutzky,Deepak Mittal,Kimberley Stannard,Thomas S. Watkins,Champa N. Ratnatunga,Corey Smith,Helen M. McGuire,Roslyn A. Kemp,Pamela Mukhopadhyay,Nicola Waddell,Mark J. Smyth,William C. Dougall,John J. Miles	29
7	A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment 2017 ·Cancer Research ·Arabella Young,Shin Foong Ngiow,(unknown),Ann‐Marie Patch,Deborah S. Barkauskas,Meriem Messaoudene,Gene Lin,Jérôme D. Coudert,Kimberley Stannard,Laurence Zitvogel,Mariapia A. Degli‐Esposti,Éric Vivier,Nicola Waddell,Joel Linden,Nicholas D. Huntington,Fernando Souza-Fonseca-Guimarães,Mark J. Smyth	296
8	Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis 2017 ·OncoImmunology ·Eva Maria Putz,Camille Guillerey,Kevin Kos,Kimberley Stannard,Kim Miles,Rebecca B. Delconte,Kazuyoshi Takeda,Sandra E. Nicholson,Nicholas D. Huntington,Mark J. Smyth	48
9	Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases 2017 ·OncoImmunology ·Dipti Vijayan,Deborah S. Barkauskas,Kimberley Stannard,Erin Sult,Rebecca A. Buonpane,Kazuyoshi Takeda,Michele W.L. Teng,Kris F. Sachsenmeier,Carl Hay,Mark J. Smyth	22
10	Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy 2016 ·Cancer Discovery ·Stephen J. Blake,Kimberley Stannard,Jing Liu,Stacey Allen,Michelle C.R. Yong,Deepak Mittal,Amelia Roman Aguilera,John J. Miles,Viviana P. Lutzky,Lucas Ferrari de Andrade,Ludovic Martinet,Marco Colonna,Kazuyoshi Takeda,Florian Kühnel,Engin Gürlevik,Günter Bernhardt,Michele W.L. Teng,Mark J. Smyth	187
11	Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis 2016 ·Cancer Research ·Deepak Mittal,Debottam Sinha,Deborah S. Barkauskas,Arabella Young,Murugan Kalimutho,Kimberley Stannard,Franco Caramia,Benjamin Haibe‐Kains,John Stagg,Kum Kum Khanna,Sherene Loi,Mark J. Smyth	142
12	Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAF^V600E melanoma 2015 ·OncoImmunology ·Shin Foong Ngiow,Katrina Meeth,Kimberley Stannard,Deborah S. Barkauskas,Gideon Bollag,Marcus Bosenberg,Mark J. Smyth	30
13	Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma 2014 ·Cancer Research ·Lucas Ferrari de Andrade,Shin Foong Ngiow,Kimberley Stannard,Sylvie Rusakiewicz,Murugan Kalimutho,Kum Kum Khanna,Siok‐Keen Tey,Kazuyoshi Takeda,Laurence Zitvogel,Ludovic Martinet,Mark J. Smyth	81
14	Co-blockade of immune checkpoints and adenosine A_2Areceptor suppresses metastasis 2014 ·OncoImmunology ·Arabella Young,Deepak Mittal,Kimberley Stannard,Michelle C.R. Yong,Michele W.L. Teng,Bertrand Allard,John Stagg,Mark J. Smyth	21
15	Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor 2014 ·Cancer Research ·Deepak Mittal,Arabella Young,Kimberley Stannard,Michelle C.R. Yong,Michele W.L. Teng,Bertrand Allard,John Stagg,Mark J. Smyth	211
16	Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment 2012 ·Cancer and Metastasis Reviews ·Koichi Ito,Kimberley Stannard,(unknown),Amanda M. Clark,Shiyong Neo,(unknown),Helen Blanchard,Stephen J. Ralph	106
17	Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model 2010 ·Cancer Letters ·Kimberley Stannard,P.M. Collins,Koichi Ito,Emily Sullivan,(unknown),(unknown),I. Darren Grice,Pauline Low,Ulf J. Nilsson,Hakon Leffler,Helen Blanchard,Stephen J. Ralph	84

About Kimberley Stannard

Kimberley Stannard is a scholar working on Physiology, Immunology and Oncology, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Adenosine and Purinergic Signaling (5 papers). The work is most often cited by research in Physiology (358 citations), Immunology (1.1k citations) and Oncology (941 citations). Kimberley Stannard has collaborated with scholars based in Australia, Japan and France. Frequent co-authors include Mark J. Smyth, Michele W.L. Teng, Deepak Mittal, Arabella Young, John Stagg, Michelle C.R. Yong, Deborah S. Barkauskas, Kazuyoshi Takeda, Ludovic Martinet and Bertrand Allard. Their work appears in journals such as Blood, Cancer Research and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact